While efforts to eradicate poliomyelitis have been ongoing for decades, significant progress has been made in reducing polio cases by 99% over the last 30 years.
However, the last steps in eradicating the disease are proving to be the most challenging, as recent data indicates a resurgence of polio in 2024.
According to the latest Global Polio Eradication Initiative (GPEI) report, five countries reported new polio cases this week.
As of July 24, 2024, Pakistan reported a wild poliovirus type 1 (WPV1) case. This is the ninth WPV1 case reported in Pakistan this year.
Polio Cases Surge in July 2024
Herpes Zoster Vaccination Associated with Delay in Dementia
According to a new study published by the journal Nature Medicine, there is emerging evidence that the live herpes zoster (shingles) vaccine might protect against dementia.
However, whether the GlaxoSmithKline plc's Shingrix® recombinant shingles vaccine protects against dementia remains unknown.
The WHO Teams Up Supporting Healthy Paris Olympics 2024
The World Health Organization (WHO) announced it will participate in the Paris Olympics 2024 in multiple fields, supporting the International Olympic Committee (IOC) and France to help make the world’s leading sports spectacle healthy and safe for spectators and athletes.
Don't End Summer Vacation With Dengue
As the end of Summer 2024 approaches and students prepare to return to school, the idea of getting a last-minute vaccination and heading to a warm beach sounds appealing.
However, with the global outbreak of dengue fever expanding in the Region of the Americas, it's crucial to choose a destination that is free from disease-carrying mosquitoes.
As of July 25, 2024, 43 countries and territories in the Region had reported over 10.8 million dengue cases and 5,848 related deaths.
18.3 Percent of Physicians Reported PTSD During COVID-19 Pandemic
Increased likelihood seen for female physicians, older physicians, and trainees, and for emergency department doctors
$25 Million Boosts Clinical Trials Conducted at Pharmacies
When the U.S. government approves a vaccine, the clinical trial process does not stop. The fourth type of clinical evaluation is called Phase 4 or Post-Market Survalence.
These studies aggregate real-world evidence that hopefully meets or extends results reported in the pre-approval clinical trial.
Dog Importation Rules Clarified by the U.S. CDC
The U.S. Centers for Disease Control and Prevention (CDC) released a media statement with an updated process for bringing dogs into the United States from rabies-free and low-risk dog rabies countries to simplify and clarify the procedures.
Telehealth Only Partially Offset Decreased Primary Care Visits During Pandemic
Magnitude of these changes varied significantly by patient demographic characteristics
Long COVID Incidence Declined Over Course of Pandemic
However, authors say, risk remains substantial even among vaccinated persons during the omicron era
Social Distancing Measures Tied to Neonatal Mortality With Lag Period
With two-month lag period, social distancing index linked to higher neonatal and early neonatal mortality rates